Cerenome, Inc. (PSTV)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $3.87
- As of
Kresmion compiles this page from PSTV's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
CERENOME, INC. (PSTV): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-02.
See the full PSTV dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PSTV on one page. Preview it with sample data, then open it live with a free account.
Preview the PSTV dossierActive signals for PSTV
- mediumNEW_POSITION
MILLENNIUM MANAGEMENT LLC new position in PSTV
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 121.8% - EPS $0.5 vs $-2.295 estimate
- mediumEARNINGS_MISS
Q3-2025: Missed consensus by 96.1% - EPS $-1 vs $-0.51 estimate
- mediumEARNINGS_BEAT
Beat consensus by 121.8% - EPS $0.5 vs $-2.295 estimate
- mediumEARNINGS_MISS
Missed consensus by 96.1% - EPS $-1 vs $-0.51 estimate
FREE, NO ACCOUNT
Every signal on PSTV, as it fires
You are seeing 5 of 7 signals recorded on PSTV since 2026-05-27.
The five above landed across 3 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, PSTV
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
PSTV against its peers
PSTV's operating margin of -293.5% ranks in the 94th percentile of 7 Biotechnology sub-industry peers, fiscal periods ending between 2025-06-30 and 2025-12-31.
| Metric | PSTV | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 5.2M USD | 336108 USD | 75 | 9 |
| Operating margin | -293.5% | -1575.3% | 94 | 7 |
| Net margin | -429.4% | -1073.3% | 61 | 8 |
| Return on equity | -560.2% | -89.5% | 4 | 13 |
| 1 year | n/a | -69.5% | n/a | 12 |
Peers (18): ABVC, HOTH, GRDX, ATYR, IMMP, QNCX, KYNB, MCRB, RNAZ, NXTC, CNTX, BRNS, CMND, ATOS, SGMO, PVCT, BYSI, QNRX. Left out: TTIPF (no annual filing), EVAX (no annual filing), MDNAF (no annual filing), IGC (no annual filing), SEOVF (no annual filing), PLRZ (no annual filing), CLCS (period gap). Fiscal periods ending between 2025-06-30 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (PSTV: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow PSTV on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to PSTV for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.